Osteonecrosis and bone infarction in association with Behcet's disease: Report of two cases

Clinical and Experimental Rheumatology

Volumn 19, Issue 5 SUPPL. 24, 2001, Pages

  Chang, H K ^a   Choi, Y J ^a   Baek, S K ^a   Lee, D H ^a   Won, K S ^a  

^a University of Ulsan   (South Korea)

Author keywords

Anticardiolipin antibodies; Beh et's disease; Bone infarction; Osteonecrosis

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; ARTICLE; BEHCET DISEASE; BONE NECROSIS; CASE REPORT; FEMALE; FEMUR HEAD NECROSIS; HUMAN; KNEE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; BEHCET SYNDROME; CASE REPORT; FEMALE; FEMUR HEAD NECROSIS; HUMAN; KNEE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGE; OSTEONECROSIS;

EID: 17144469911     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. COOGAN PG, URBANIAK JR: Osteonecrosis. In: KELLY WN, HARRIS ED, RUDDY S, SLEDGE CB (Eds): Textbook of Rheumatology. Philadelphia, WB Saunders 1997: 1581-92.
2. RESNICK D, SWEET DE, MADEWELL JE: Osteonecrosis and osteochondrosis. In: RESNICK D (Ed): Bone and Joint Imaging. Philadelphia, W.B. Saunders 1996: 941-59.
3. MONT MA, HUNGERFORD DS: Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg 1995; 77A: 459-74.
4. RONCO P, WECHSLER B, SAILLANT G, GODEAU P: Aseptic osteonecrosis during corticosteroid treatment of Behcet's disease. Nouv Presse Med 1981; 10: 1707-10.
5. International Study Group for Behcet's disease: Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078-80.
6. HUREL SJ, KENDALL-TAYLOR P: Avascular necrosis secondary to postoperative steroid activity. Br Neurosurg 1997; 11: 356-8.
7. SIMKIN PA, GARDNER GC: Osteonecrosis: Pathogenesis and practicalities. Hosp Pract 1994; 29: 73-8, 81-4.
8. MONT MA, GLUECK CJ, PACHECO IH, WANG P, HUNGERFORD DS, PETRI M: Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997; 24: 654-62.
9. COZEN L, WALLACE DJ: Avascular necrosis in systemic lupus erythematosus: clinical associations and a 47-year perspective. Am J Orthop 1998; 27: 352-4.
10. MIGLIARESI S, PICILLO U, AMBROSONE L, et al.: Avascular osteonecrosis in patients with SLE: Relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994; 3: 37-41.
11. HULL RG, HARRIS EN, GHARAVI AE, et al.: Anticardiolipin antibodies: Occurrence in Behcet's syndrome. Ann Rheum Dis 1984; 43: 746-8.
12. ZOUBOULIS CC, BÜTTNER P, TEBBE B, ORFANOS CE: Anticardiolipin antibodies in Adamantiades-Behcet's disease. Br J Dermatol 1993; 128: 281-4.
13. MADER R, ZIV M, ADAWI M, MADER R, LAVI I: Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet's disease. J Rheumatol 1999; 26: 2404-8.
14. KANG HJ, LEE YW, HAN SH, CHO HC, LEE KM: Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease. J Korean Med Sci 1998; 13: 400-4.
15. AL-DALAAN AN, AL-BALLAA SR, AL-JANADI MA, BOHLEGA S, BAHABRI S: Association of anticardiolipin antibodies with vascular thrombosis and neurological manifestation of Behcet's disease. Clin Rheumatol 1993; 12: 28-30.
16. GUERMAZI S, HAMZA M, DELLAGI K: Protein S deficiency and antibodies to protein S in patients with Behcet's disease. Thromb Res 1997; 86: 197-204.
17. PRIORI R, CONTI F, PITTONI V, GAROFALO T, SORICE M, VALESINI G: Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease? Thromb Haemost 2000; 83: 173-4.
18. GREAVES M: Antiphospholipid antibodies and thrombosis. Lancet 1999; 353: 1348-1353.
19. PENGO V, BIASIOLO A, BROCCO T, TONETTO S, RUFFATTI A: Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 1996; 75: 721-4.
20. SWADZBA J, DE CLERCK LS, STEVENS WJ, et al.: Anticardiolipin, anti-2-glycoprotein I, antithrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997; 24: 1710-5.
21. SILVER RM, PORTER TF, VAN LEEUWEEN I, JENG G, SCOTT JR, BRANCH DW: Anticardiolipin antibodies: Clinical consequences of 'low titers'. Obst Gynecol 1996; 87: 494-500.
22. FINAZZI G, BRANCACCIO V, MOIA M, et al.: Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian Registry. Am J Med 1996; 100: 530-6.
23. ASHERSON RA, BAGULEY E, PAL C, HUGHES GRV: Antiphospholipid syndrome: Five year follow up. Ann Rheum Dis 1991; 50: 805-10.
24. KOROMPILIAS AV, GILKESON GS, ORTEL TL, SEABER AV, URBANIAK JR: Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop 1997; 345: 174-80.
25. ASHERSON RA, CERVERA R: Antiphospholipid syndrome. In: KELLY WN, HARRIS ED, RUDDY S, SLEDGE CB (Eds.): Textbook of Rheumatology. Philadelphia, WB Saunders 1997: 1057-64.
26. ASHERSON RA, KHAMASHTA MA, ORDI-ROS J, et al.: The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-74.